Bacterial Infection
Conditions
Interventions
Elacycline treatment group:None
Sponsors
Huashan hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Receive at least 1 dose of eravacycline during hospitalization. 2. Age =18 at the time of signing the informed consent. 3. Voluntarily participate in the study and sign the informed consent. If the subject is unable to read and/or sign the informed consent due to incapacity or other reasons, his/her guardian shall represent the informed process and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Enrolling in any other clinical trials, including non-interventional studies. 2. Incomplete or absent medical history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical outcome(i.e. treatment success, treatment failure or uncertain outcome);Microbial outcome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions and drug resistance during treatment;Hospitalization days;Hospitalization expenses;The recurrence rate of infection; | — |
Countries
China
Contacts
Public ContactHuang haihui
Institute of Antibiotics Huashan Hospital, Fudan University,12 M. Wulumuqi Road,Shanghai 200040, China
Outcome results
None listed